Gestational diabetes after infertility treatment for polycystic ovarian syndrome.
نویسندگان
چکیده
P ovarian syndrome (PCOS) and gestational diabetes (GDM) are both insulin resistant conditions. Women with PCOS are at least twice as likely to develop GDM; they may be infertile and need to seek medical assistance to conceive. Fetal and maternal outcomes of assisted pregnancies in the setting of PCOS are unknown. We propose to document in a retrospective study, pregnancy outcomes in women with PCOS who delivered term pregnancies after infertility treatment. Women with PCOS as defined by the National Institute of Health (NIH), who had attended an infertility clinic between August 2000 and August 2006 at the University Hospital of the London Health Sciences Centre, Ontario, Canada, were sent a letter requesting permission for us to contact them by telephone. Upon receipt of their written consents, the women were contacted by telephone and were requested to answer a questionnaire. This questionnaire documented maternal and neonatal demographic data; permission were requested from the mothers to examine their medical records, as well as their infant’s neonatal records. We only recorded outcome from singleton pregnancies. Outcomes of interest include: maternal birth weight, types of medications used for conception along with cycles of infertility treatment needed until conception, week of onset of GDM, need for insulin, infant birth weights, duration of hospitalization, post natal diagnosis of diabetes, hypertension, and dyslipidemia. We obtained ethical approval of the study from the University of Western Ontario. The student t test was used in the statistical analysis. Twenty-seven women were identified as having PCOS and had attended the clinic, but 3 were excluded from any analysis, as they do not have singleton pregnancies. The mean age was 36.4 ± 4.7 years. The mean time to conceive was 10.6 ± 18.6 months. Infertility treatments included; 14 women used Metformin, 25 used Clomid, one used Femara, 17 used Pergonal, and 18 women required intrauterine insemination. Gestational diabetes were diagnosed in 6 women (25%) and 2 were treated with insulin. Gestational diabetes and non-GDM women were similar in age, years on birth control pills, months to conception, and week of delivery. No significant differences were found between infant birth weights or infant length of stay in the hospital, when comparing GDM and non-GDM pregnancies. More women with GDM had cesarean section deliveries (50% versus 25%, p=0.05). They also reported significantly lower personal birth weights than women without GDM (2830.2 ± 611.6 g versus 3430.3 ± 505.1 g, p=0.02). No significant correlations were found between maternal birth weight and infant birth weight, or between maternal birth weight and months taken to conceive (Table 1). Within one year after delivery, 2 women had been diagnosed with diabetes, 2 with hypertension, and the other 2 with dyslipidemia. Women with PCOS have a significant higher chance of developing GDM and abnormal glucose tolerance test independent of their body mass index (BMI).1 Both conditions represent insulin resistance states, with relative impairment of insulin secretion occurring in women with GDM.2 Previous studies have shown no important differences in women treated for infertility in singleton infant outcomes evaluated for premature delivery, Apgar scores, pre-eclampsia, and neonatal malformations. A recent meta-analysis by Boomsma et al3 that includes 778 pregnancies, they observed that there were significant association between PCOS and maternal GDM, pregnancy induced hypertension, pre-eclampsia, and delivery by cesarean section. It also demonstrated a higher risk of neonatal admission to the neonatal intensive care unit, as well as premature deliveries among offspring born to women with PCOS. Birth weights of the infants of PCOS women were significantly lower compared with controls, in spite of higher incidence of GDM in this group, although it is possible that a higher incidence of pregnancy induced hypertension and pre-eclampsia causing placental insufficiency explained this observation.
منابع مشابه
Inm-2: Polycystic Ovarian Syndrome is a Potent Risk Factor for GDM in Infertile Patient
Objective: Gestational diabetes mellitus (GDM), a common medical complication of pregnancy, is defined as “any degree of glucose intolerance with onset or first recognition during pregnancy.Risk factors for GDM: a previous GDM or Pre diabetes , a family history revealing a first degree relative with type 2 diabetes , maternal age (>35yr), ethnic background , being overweight , a previous pregna...
متن کاملP-159: Women's Infertility and Polycystic Ovarian Syndrome, Concepts and Treatment
Background: Polycystic ovarian syndrome (PCOS) is a medical condition that affects women's menstrual cycles, fertility, hormone levels, and physical appearance. PCOS is thought to be one of the leading causes of female infertility, and is the reason of more than 75% of cases of anovulatory infertility. Materials and Methods: In this article, we review the different aspects of PCOS includin...
متن کاملSuccessful Treatment of Polycystic Ovarian Syndrome, Nonalcoholic Fatty Liver Disease and Infertility with Chinese Herbal Medicine: A Case Report
This case report details a 30 year old woman with hyperlipidemia, Nonalcoholic Fatty Liver Disease (NAFLD), Polycystic Ovarian Syndrome (PCOS) and infertility. Her impaired liver function has prevented the use of pharmaceutical drugs (statins and metformin). The patient therefore underwent two stages of Chinese herbal medicine treatment: the first formula to ameliorate hyperlipidemia and amenor...
متن کاملAssociation of Metformin Pharmacogenetic with a Single Amino Acid Alteration in Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Genein Patients with Polycystic Ovary Syndrome
Introduction: Polycystic ovarian syndrome (PCOS) is known as a metabolic, reproductive and ovarian degeneration disorder. Pro12 Ala mutation in peroxisome proliferator-activated receptor gamma (PPARγ) gene as a transcription factor is linked to disorder of glucose and infertility. In the patients with type 2 diabetes and polycystic ovary syndrome, metformin is the recommended first-line treatme...
متن کاملInvestigating the Impact of Metformin Consumption on the Incidence of Gestational Diabetes and Preeclampsia in Pregnant Women Suffering Polycystic Ovary Syndrome: A Clinical Trial Study
Background Women with polycystic ovary syndrome (PCOS) are at higher risk of developing pregnancy complications including gestational diabetes and preeclampsia. This study was performed with the aim of examining the impact of metformin on incidence of gestational diabetes and preeclampsia in pregnant women with PCOS. <s...
متن کاملTCRM-3779-Current trends in the treatment of polycystic ovary
Correspondence: Miguel Angel Checa Servicio de Obstetricía y Ginecología, Hospital del Mar, Paseo Marítimo 25-25, Barcelona 08003, Spain Tel +34 932483129 Fax +34 932483254 email [email protected] Abstract: Polycystic ovary syndrome (PCOS), one of the most frequent endocrine diseases, affects approximately 5%–10% of women of childbearing age and constitutes the most common cause of fem...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Saudi medical journal
دوره 30 4 شماره
صفحات -
تاریخ انتشار 2009